Issuer · CIK 0001822462

FHTX — Foghorn Therapeutics Inc.

Recent filings

Feb 6, 2026·Form 4·Other$5.6M
FHTX/Foghorn Therapeutics Inc.
GOTTSCHALK ADRIAN · Chief Executive Officer
Mechanical filing
AI thesis skipped

← Back to all filings